APOTHEEK MICHIELS
ActiveAPOTHEEK MICHIELS has been active since 1990 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.63M and a net result of €119k. Equity is growing by ~3.9% per year across the filed fiscal years. Its solvency ranks better than 82% of 10310 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
81
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability75▼-2
Solvency97▲+3
Growth78=
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €130k at 30 days acceptable
Liquidity ample (current ratio 4.34 against 3.96 in 2024; short-term debt: 21.8% and cash: 15.7% of total assets), and 28.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
71.5%
Return on assets
5.2%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
31 d late
2024
21 d late
2023
6 d early
2022
35 d early
2021
30 d late
2020
19 d early
2019
27 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€1.63M▲ 5.8%
2024 · €1.55M
2018: €1.25M
2019: €1.28M
2020: €1.30M
2021: €1.38M
2022: €1.48M
2023: €1.48M
2024: €1.55M
2018 → 2025
Total assets
€2.29M▲ 1.9%
2024 · €2.24M
2018: €1.49M
2019: €1.56M
2020: €1.67M
2021: €1.95M
2022: €2.26M
2023: €2.35M
2024: €2.24M
2018 → 2025
Net result
€119k▼ 20.6%
2024 · €150k
2018: €84k
2019: €105k
2020: €139k
2021: €134k
2022: €123k
2023: €130k
2024: €150k
2018 → 2025
Working capital
€1.66M▲ 8.4%
2024 · €1.53M
2018: €1.21M
2019: €1.26M
2020: €1.27M
2021: €1.34M
2022: €1.40M
2023: €1.42M
2024: €1.53M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€1.38M-€1.48M▲ 7.1%€1.48M=€1.55M▲ 4.7%€1.63M▲ 5.8%
Operating result€158k-€148k▼ 6.1%€143k▼ 3.2%€187k▲ 30.6%€165k▼ 11.6%
Net result€134k-€123k▼ 8.2%€130k▲ 6.3%€150k▲ 14.7%€119k▼ 20.6%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 12% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.29M
Fixed assets
€124k▼ 35.0%
Current assets
€2.16M▲ 5.3%
Equity and liabilities €2.29M
Equity
€1.63M▲ 5.8%
Debt
€652k▼ 6.7%
The debt ratio falls from 31.1% to 28.5%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€232k▼
2024 · €259k
Cash flow
€186k▼
2024 · €222k
Solvency
71.5%▲
2024 · 68.9%
Current ratio
4.34▲
2024 · 3.96
Quick ratio
3.51▲
2024 · 3.20
Debt / equity
0.40▼
2024 · 0.45
ROE
7.3%▼
2024 · 9.7%
ROA
5.2%▼
2024 · 6.7%
Interest coverage
17.06▼
2024 · 18.29
Debt
€652k▼
2024 · €699k
Debt ≤ 1 year
€499k▼
2024 · €519k
Debt > 1 year
€148k▼
2024 · €175k
Income taxes
€36k▲
2024 · €27k
Staff costs
€276k▲
2024 · €200k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€2.24M€2.29M▲
Fixed assets21/28€191k€124k▼
Tangible fixed assets22/27€186k€119k▼
Land and buildings22€3k€1k▼
Plant, machinery and equipment23€143k€83k▼
Furniture and vehicles24€7k€3k▼
Other tangible fixed assets26€33k€32k▼
Financial fixed assets28€5k€5k=
Current assets29/58€2.05M€2.16M▲
Stocks and contracts in progress3€393k€412k▲
Stocks30/36€393k€412k▲
Amounts receivable within one year40/41€1.37M€1.36M▼
Trade receivables40€157k€216k▲
Other amounts receivable41€1.21M€1.15M▼
Current investments50/53-€1,000
Cash at bank and in hand54/58€266k€360k▲
Deferred charges and accrued income490/1€27k€25k▼
Equity and liabilities
Total equity and liabilities10/49€2.24M€2.29M▲
Equity10/15€1.55M€1.63M▲
Contributions10/11€500k€500k=
Reserves13€284k€284k=
Non-distributable reserves130/1€49k€49k=
Reserves not available under the articles1311€49k€49k=
Distributable reserves133€235k€235k=
Profit (loss) carried forward14€762k€850k▲
Amounts payable17/49€699k€652k▼
Amounts payable after more than one year17€175k€148k▼
Financial debts170/4€175k€148k▼
Amounts payable within one year42/48€519k€499k▼
Current portion of amounts payable after more than one year42€27k€27k▲
Trade debts44€282k€337k▲
Suppliers440/4€282k€337k▲
Taxes, remuneration and social security45€53k€34k▼
Taxes450/3€11k€2k▼
Remuneration and social security454/9€42k€31k▼
Other amounts payable47/48€157k€101k▼
Accrued charges and deferred income492/3€5k€5k▲
Income statement
Code20242025
Non-recurring operating income76A-€739
Remuneration, social security and pensions62€200k€276k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€72k€67k▼
Other operating charges640/8€1k€1k▲
Gross operating margin9900€460k€510k▲
Operating profit (loss)9901€187k€165k▼
Financial income75/76B€4k€3k▼
Recurring financial income75€4k€3k▼
Financial charges65/66B€14k€14k▼
Recurring financial charges65€14k€14k▼
Profit (loss) for the period before taxes9903€177k€155k▼
Income taxes67/77€27k€36k▲
Profit (loss) for the period9904€150k€119k▼
Profit (loss) for the period to be appropriated9905€150k€119k▼
Appropriation of the result
Profit (loss) to be appropriated9906€842k€880k▲
Profit (loss) brought forward from the previous period14P€692k€762k▲
Profit to be distributed694/7€80k€30k▼
Directors or managers695€80k€30k▼
Social balance
Average headcount (FTE)90873.94.8▲
The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 31 days late
2025
21-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 21 days late
2024
31-12
Financial
Highest result since 2018net €150k ▲14.7%
Operating result €187k, net result €150k, both a record.
25-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
26-06
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
30-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 30 days late
2021
12-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
27-08
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 27 days late
2019
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 30 days late
2018
25-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
29-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zoersel · 1 establishment unit since 1991
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Antwerpsedreef 22980 ZoerselGround area
2,066 m²
Building footprint
527 m²
Volume, LiDAR
5,858 m³
2 parcels, Flanders · tallest building 19.2 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK MICHIELS
since 19912.051.660.163
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11055D0034/00H004 | Flanders | 1,241 m² | 1 · 210 m² | 9.1 m · 2 fl. |
| 11055D0102/00B002 | Flanders | 824 m² | 1 · 317 m² | 19.2 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteZoersel2.051.660.163
Similar companies · same sector, comparable size
APOTHEEK KAREN LIEVENS
BE 0414.457.541
Lokeren · Eq €1.63M
INGE THOELEN
BE 0895.720.863
Landen · Eq €1.63M
APOTHEEK 'T HOUTEN KRUIS
BE 0476.200.318
Waasmunster · Eq €1.63M
Apoteek Jespers - Cuijpers
BE 0440.256.175
Anderlecht · Eq €1.63M
PHARMALORRAINE
BE 0455.089.059
Aubange · Eq €1.62M
Of 5,223 companies in sector 47730 we hold annual accounts for 3,862. 2,594 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded17-12-1990
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 35 filingsAddress and cadastre registers
Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.